Publication: Is it safe to perform adenotonsillectomy in children with Down syndrome?
dc.contributor.author | BİNNETOĞLU, ADEM | |
dc.contributor.authors | Yumusakhuylu, Ali Cemal; Binnetoglu, Adem; Demir, Berat; Baglam, Tekin; Sari, Murat | |
dc.date.accessioned | 2022-03-12T20:29:03Z | |
dc.date.available | 2022-03-12T20:29:03Z | |
dc.date.issued | 2016 | |
dc.description.abstract | This retrospective review aims to evaluate the postoperative morbidity and mortality of 30 patients with Down syndrome who underwent adenotonsillectomy between June 2012 and December 2015 in a tertiary referral center. Mean age was 7.8 with a range of 3-12. There were 20 (66.6 %) male and ten (33.3 %) female patients. Mean follow-up was 23 months with a range of 7-43 months. 23 (76.6 %) of 30 patients had been operated due to obstructive tonsillar and adenoid hypertrophy, whereas seven (23.3 %) of them operated for chronic recurrent infections. All of the patients had undergone adenotonsillectomy operation; one patient had also bilateral tympanostomy tube insertion. Hospital stay was noted 1.3 days in average with a range of 1-3 days. Anesthetic complications of persistent bradycardia and postextubation respiratory difficulty occurred in two (6.6) patients. Patient who had intraoperative bradycardia necessitated intensive care unit stay and pacemaker implantation during follow-up. 3 (10 %) patients had late onset hemorrhage between days 7 and 10 and required intraoperative bleeding control. We did not experience any other morbidity and mortality except the abovementioned ones. In conclusion, adenotonsillectomy in patients with Down syndrome is a worthwhile operation with certain risks and these operations should better be performed by the tertiary referral centers which have the capacity to deal with the complications. | |
dc.identifier.doi | 10.1007/s00405-016-4012-7 | |
dc.identifier.eissn | 1434-4726 | |
dc.identifier.issn | 0937-4477 | |
dc.identifier.pubmed | 27020270 | |
dc.identifier.uri | https://hdl.handle.net/11424/234018 | |
dc.identifier.wos | WOS:000381264100070 | |
dc.language.iso | eng | |
dc.publisher | SPRINGER | |
dc.relation.ispartof | EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Down syndrome | |
dc.subject | Tonsillectomy | |
dc.subject | Adenoidectomy | |
dc.subject | Complication | |
dc.subject | Bradycardia | |
dc.subject | Obstructive sleep apnea | |
dc.subject | OBSTRUCTIVE SLEEP-APNEA | |
dc.subject | AIRWAY-OBSTRUCTION | |
dc.subject | ADENOIDECTOMY | |
dc.subject | TONSILLECTOMY | |
dc.subject | SEVOFLURANE | |
dc.subject | INSTABILITY | |
dc.subject | TRISOMY-21 | |
dc.subject | INDUCTION | |
dc.subject | PATTERNS | |
dc.title | Is it safe to perform adenotonsillectomy in children with Down syndrome? | |
dc.type | article | |
dspace.entity.type | Publication | |
local.avesis.id | 164ca92d-7a78-44bf-aba2-374e53743d95 | |
local.import.package | SS17 | |
local.indexed.at | WOS | |
local.indexed.at | SCOPUS | |
local.indexed.at | PUBMED | |
local.journal.numberofpages | 5 | |
local.journal.quartile | Q2 | |
oaire.citation.endPage | 2823 | |
oaire.citation.issue | 9 | |
oaire.citation.startPage | 2819 | |
oaire.citation.title | EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY | |
oaire.citation.volume | 273 | |
relation.isAuthorOfPublication | 7d22b68b-082d-4ffc-95cf-2646bb131363 | |
relation.isAuthorOfPublication.latestForDiscovery | 7d22b68b-082d-4ffc-95cf-2646bb131363 |